73 related articles for article (PubMed ID: 18640288)
21. Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells.
Rizzo A; Misso G; Bevilacqua N; Donnarumma G; Lombardi A; Galdiero M; Caraglia M
Int Immunopharmacol; 2014 Sep; 22(1):66-72. PubMed ID: 24975838
[TBL] [Abstract][Full Text] [Related]
22. Heat-inactivated C. pneumoniae organisms are not atherogenic.
Sharma J; Niu Y; Ge J; Pierce GN; Zhong G
Mol Cell Biochem; 2004 May; 260(1-2):147-52. PubMed ID: 15228096
[TBL] [Abstract][Full Text] [Related]
23. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E-deficient mice develop an anti-Chlamydophila pneumoniae T helper 2 response and resist vascular infection.
Nazzal D; Therville N; Yacoub-Youssef H; Garcia V; Thomsen M; Levade T; Segui B; Benoist H
J Infect Dis; 2010 Sep; 202(5):782-90. PubMed ID: 20632890
[TBL] [Abstract][Full Text] [Related]
25. Chlamydia pneumoniae infection enhances microglial activation in atherosclerotic mice.
Voorend M; van der Ven AJ; Mulder M; Lodder J; Steinbusch HW; Bruggeman CA
Neurobiol Aging; 2010 Oct; 31(10):1766-73. PubMed ID: 19027992
[TBL] [Abstract][Full Text] [Related]
26. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response.
Kaukoranta-Tolvanen SS; Teppo AM; Laitinen K; Saikku P; Linnavuori K; Leinonen M
Microb Pathog; 1996 Sep; 21(3):215-21. PubMed ID: 8878018
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptors 2 and 4 do not contribute to clearance of Chlamydophila pneumoniae in mice, but are necessary for the release of monokines.
Mueller M; Postius S; Thimm JG; Gueinzius K; Muehldorfer I; Hermann C
Immunobiology; 2004; 209(8):599-608. PubMed ID: 15638128
[TBL] [Abstract][Full Text] [Related]
28. Increased inflammation and impaired resistance to Chlamydophila pneumoniae infection in Dusp1(-/-) mice: critical role of IL-6.
Rodriguez N; Dietrich H; Mossbrugger I; Weintz G; Scheller J; Hammer M; Quintanilla-Martinez L; Rose-John S; Miethke T; Lang R
J Leukoc Biol; 2010 Sep; 88(3):579-87. PubMed ID: 20483921
[TBL] [Abstract][Full Text] [Related]
29. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
[TBL] [Abstract][Full Text] [Related]
30. Chronic and repeated Chlamydophila pneumoniae lung infection can result in increasing IL-4 gene expression and thickness of airway subepithelial basement membrane in mice.
Chen CZ; Yang BC; Lin TM; Lee CH; Hsiue TR
J Formos Med Assoc; 2009 Jan; 108(1):45-52. PubMed ID: 19181607
[TBL] [Abstract][Full Text] [Related]
31. Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.
Han X; Xu Y; Wang J; Pei X; Yang R; Li N; Li Y
Bone; 2009 May; 44(5):942-7. PubMed ID: 19124090
[TBL] [Abstract][Full Text] [Related]
32. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
33. Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice.
Marangoni A; Fiorino E; Gilardi F; Aldini R; Scotti E; Nardini P; Foschi C; Donati M; Montagnani M; Cevenini M; Franco P; Roda A; Crestani M; Cevenini R
Atherosclerosis; 2015 Aug; 241(2):471-9. PubMed ID: 26086356
[TBL] [Abstract][Full Text] [Related]
34. Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis.
Yavuz MT; Yavuz O; Yazici M; Guler S; Ozhan H; Albayrak S; Coskun A
Scand J Clin Lab Invest; 2006; 66(6):523-34. PubMed ID: 17000560
[TBL] [Abstract][Full Text] [Related]
35. The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis.
Campbell LA; Yaraei K; Van Lenten B; Chait A; Blessing E; Kuo CC; Nosaka T; Ricks J; Rosenfeld ME
Microbes Infect; 2010 Aug; 12(8-9):598-606. PubMed ID: 20417302
[TBL] [Abstract][Full Text] [Related]
36. Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model.
Rantakokko J; Uusitalo H; Jämsä T; Tuukkanen J; Aro HT; Vuorio E
J Bone Miner Res; 1999 Nov; 14(11):1934-42. PubMed ID: 10571694
[TBL] [Abstract][Full Text] [Related]
37. The association of carotid plaque inflammation and Chlamydia pneumoniae infection with cerebrovascular symptomatology.
Kaperonis EA; Liapis CD; Kakisis JD; Perrea D; Kostakis AG; Karayannakos PE
J Vasc Surg; 2006 Dec; 44(6):1198-204. PubMed ID: 17145421
[TBL] [Abstract][Full Text] [Related]
38. Involvement of TNFalpha -308A promoter polymorphism in the development of asthma in children infected with Chlamydophila pneumoniae.
Tölgyesi G; Keszei M; Ungvári I; Nagy A; Falus A; Szalai C
Pediatr Res; 2006 Nov; 60(5):543-8. PubMed ID: 16988194
[TBL] [Abstract][Full Text] [Related]
39. Exposure to cigarette smoke and Chlamydia pneumoniae infection in mice: Effect on infectious burden, systemic dissemination and cytokine responses: A pilot study.
Kumar S; Smith-Norowitz TA; Kohlhoff S; Apfalter P; Roblin P; Kutlin A; Harkema J; Ng SP; Doherty-Lyons S; Zelikoff JT; Hammerschlag MR
J Immunotoxicol; 2016; 13(1):77-83. PubMed ID: 25640695
[TBL] [Abstract][Full Text] [Related]
40. Effect of levofloxacin on the viability of intracellular Chlamydia pneumoniae and modulation of proinflammatory cytokine production by human monocytes.
Baltch AL; Smith RP; Ritz WJ; Carpenter AN; Bopp LH; Michelsen PB; Carlyn CJ; Hibbs JR
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):205-12. PubMed ID: 15541607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
